The JCO Podcast hosted by Dr. Shannon Westin features discussions of new and noteworthy results publ
This podcast describes the analysis of the IPASS study population by EGFR mutation and EGFR FISH bio
The use of arsenic trioxide as a single agent can produce long lasting remissions and a significant
In this podcast, results of randomized phase III clinical trial evaluating the effects of a patient
The addition of oxaliplatin to fluorouracil-based neoadjvuant chemoradiation for locally advanced re
The term targeted therapy is often used in cancer drug development. This podcast will discuss the s
Commentary on a new small molecule inhibitor of angiogenesis in combination with chemotherapy for me
This SEER based study demonstrated that the advanced radiation therapy technique of three-dimensiona
This podcast will discuss the basic background of myelodysplastic syndromes and the clinical implica
This podcast describes the long term outcomes of patients treated with chemotherapy first, followed
In this week's podcast, Dr. Jaine discusses the recent manuscript by Paik and colleagues evaluating
In this podcast, Dr. Neal J. Meropol provides his perspective on two large randomized studies of vat
By Mary Daly. Stage at diagnosis of breast cancer among women with BRCA1/2 mutations was available
By David Ryan. This JCO Podcast provides observations and commentary on the JCO article, "Clinical
By Reed Drews. This JCO Podcast provides observations and commentary on the JCO article, "Safety and
By Lisa Carey. The randomized Phase III trial, Ribbon-1, was designed to examine whether the benefi
By David Avigan. This podcast describes a phase III randomized study comparing the efficacy and tox
